Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 282

1.

Limited evolution of the yellow fever virus 17d in a mouse infection model.

Kum DB, Mishra N, Vrancken B, Thibaut HJ, Wilder-Smith A, Lemey P, Neyts J, Dallmeier K.

Emerg Microbes Infect. 2019;8(1):1734-1746. doi: 10.1080/22221751.2019.1694394.

PMID:
31797751
2.

Dengue vaccine development: status and future.

Wilder-Smith A.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2019 Nov 29. doi: 10.1007/s00103-019-03060-3. [Epub ahead of print] Review.

PMID:
31784763
3.

Unprecedented rise in dengue outbreaks in Bangladesh.

Hsan K, Hossain MM, Sarwar MS, Wilder-Smith A, Gozal D.

Lancet Infect Dis. 2019 Dec;19(12):1287. doi: 10.1016/S1473-3099(19)30616-4. No abstract available.

PMID:
31782396
4.

Misguided approach to dengue vaccine risk.

Wilder-Smith A, Hombach J, Cravioto A.

Science. 2019 Nov 29;366(6469):1082-1083. doi: 10.1126/science.aaz6159. No abstract available.

PMID:
31780549
5.

Ambient Air Pollution and Mortality in 652 Cities.

Vilcassim MJR, Freedman DO, Wilder-Smith A.

N Engl J Med. 2019 Nov 21;381(21):2073-2074. doi: 10.1056/NEJMc1913285. No abstract available.

PMID:
31747735
6.

Yellow Fever in Travelers.

Wilder-Smith A.

Curr Infect Dis Rep. 2019 Oct 31;21(11):42. doi: 10.1007/s11908-019-0701-x. Review.

PMID:
31673899
7.

ZikaPLAN: addressing the knowledge gaps and working towards a research preparedness network in the Americas.

Wilder-Smith A, Preet R, Brickley EB, Ximenes RAA, Miranda-Filho DB, Turchi Martelli CM, Araújo TVB, Montarroyos UR, Moreira ME, Turchi MD, Solomon T, Jacobs BC, Villamizar CP, Osorio L, de Filipps AMB, Neyts J, Kaptein S, Huits R, Ariën KK, Willison HJ, Edgar JM, Barnett SC, Peeling R, Boeras D, Guzman MG, de Silva AM, Falconar AK, Romero-Vivas C, Gaunt MW, Sette A, Weiskopf D, Lambrechts L, Dolk H, Morris JK, Orioli IM, O'Reilly KM, Yakob L, Rocklöv J, Soares C, Ferreira MLB, Franca RFO, Precioso AR, Logan J, Lang T, Jamieson N, Massad E.

Glob Health Action. 2019;12(1):1666566. doi: 10.1080/16549716.2019.1666566.

8.

Antimicrobial use and misuse at the end of life: a retrospective analysis of a treatment escalation/limitation plan.

Wilder-Smith A, Gillespie T, Taylor DR.

J R Coll Physicians Edinb. 2019 Sep;49(3):188-192. doi: 10.4997/JRCPE.2019.304.

PMID:
31497784
9.

Incidence of Guillain-Barré Syndrome (GBS) in Latin America and the Caribbean before and during the 2015-2016 Zika virus epidemic: A systematic review and meta-analysis.

Capasso A, Ompad DC, Vieira DL, Wilder-Smith A, Tozan Y.

PLoS Negl Trop Dis. 2019 Aug 26;13(8):e0007622. doi: 10.1371/journal.pntd.0007622. eCollection 2019 Aug.

10.

Severe dengue in travellers: pathogenesis, risk and clinical management.

Halstead S, Wilder-Smith A.

J Travel Med. 2019 Oct 14;26(7). pii: taz062. doi: 10.1093/jtm/taz062.

PMID:
31423536
11.

Pre-vaccination screening strategies for the use of the CYD-TDV dengue vaccine: A meeting report.

Wilder-Smith A, Smith PG, Luo R, Kelly-Cirino C, Curry D, Larson H, Durbin A, Chu M, Tharmaphornpilas P, Ng LC, Sartori AMC, Luna EJA, Gubler DJ, España G, Yoon IK, Flasche S.

Vaccine. 2019 Aug 23;37(36):5137-5146. doi: 10.1016/j.vaccine.2019.07.016. Epub 2019 Jul 31.

PMID:
31377079
12.

Modelling an optimum vaccination strategy against ZIKA virus for outbreak use.

Massad E, Coutinho FAB, Wilder-Smith A.

Epidemiol Infect. 2019 Jan;147:e196. doi: 10.1017/S0950268819000712.

13.

Modelling the importation risk of measles during the Hajj.

Massad E, Wilder-Smith AB, Wilder-Smith A, Memish ZA.

Lancet Infect Dis. 2019 Aug;19(8):806. doi: 10.1016/S1473-3099(19)30356-1. No abstract available.

PMID:
31345448
14.

Long-Term Protection After Fractional-Dose Yellow Fever Vaccination.

Wilder-Smith A, Barrett A, Vannice K, Hombach J.

Ann Intern Med. 2019 Jul 16;171(2):145-146. doi: 10.7326/L19-0196. No abstract available.

PMID:
31307078
15.

The first licensed dengue vaccine: can it be used in travelers?

Wilder-Smith A.

Curr Opin Infect Dis. 2019 Oct;32(5):394-400. doi: 10.1097/QCO.0000000000000573.

PMID:
31305495
16.

Dengue virus-elicited tryptase induces endothelial permeability and shock.

Rathore AP, Mantri CK, Aman SA, Syenina A, Ooi J, Jagaraj CJ, Goh CC, Tissera H, Wilder-Smith A, Ng LG, Gubler DJ, St John AL.

J Clin Invest. 2019 Jul 2;130:4180-4193. doi: 10.1172/JCI128426.

17.

Model-based assessment of public health impact and cost-effectiveness of dengue vaccination following screening for prior exposure.

España G, Yao Y, Anderson KB, Fitzpatrick MC, Smith DL, Morrison AC, Wilder-Smith A, Scott TW, Perkins TA.

PLoS Negl Trop Dis. 2019 Jul 1;13(7):e0007482. doi: 10.1371/journal.pntd.0007482. eCollection 2019 Jul.

18.

The Characteristics of Informal Cancer Caregivers in the United States.

Kent EE, Mollica MA, Buckenmaier S, Wilder Smith A.

Semin Oncol Nurs. 2019 Aug;35(4):328-332. doi: 10.1016/j.soncn.2019.06.002. Epub 2019 Jun 20. Review.

PMID:
31229342
19.

Understanding the relation between Zika virus infection during pregnancy and adverse fetal, infant and child outcomes: a protocol for a systematic review and individual participant data meta-analysis of longitudinal studies of pregnant women and their infants and children.

Wilder-Smith A, Wei Y, Araújo TVB, VanKerkhove M, Turchi Martelli CM, Turchi MD, Teixeira M, Tami A, Souza J, Sousa P, Soriano-Arandes A, Soria-Segarra C, Sanchez Clemente N, Rosenberger KD, Reveiz L, Prata-Barbosa A, Pomar L, Pelá Rosado LE, Perez F, Passos SD, Nogueira M, Noel TP, Moura da Silva A, Moreira ME, Morales I, Miranda Montoya MC, Miranda-Filho DB, Maxwell L, Macpherson CNL, Low N, Lan Z, LaBeaud AD, Koopmans M, Kim C, João E, Jaenisch T, Hofer CB, Gustafson P, Gérardin P, Ganz JS, Dias ACF, Elias V, Duarte G, Debray TPA, Cafferata ML, Buekens P, Broutet N, Brickley EB, Brasil P, Brant F, Bethencourt S, Benedetti A, Avelino-Silva VL, Ximenes RAA, Alves da Cunha A, Alger J; Zika Virus Individual Participant Data Consortium.

BMJ Open. 2019 Jun 18;9(6):e026092. doi: 10.1136/bmjopen-2018-026092.

20.

Estimating the dengue burden in India.

Wilder-Smith A, Rupali P.

Lancet Glob Health. 2019 Aug;7(8):e988-e989. doi: 10.1016/S2214-109X(19)30249-9. Epub 2019 Jun 11. No abstract available.

21.

Managing severe yellow fever in the intensive care: lessons learnt from Brazil.

Kallas EG, Wilder-Smith A.

J Travel Med. 2019 Jun 11;26(5). pii: taz043. doi: 10.1093/jtm/taz043. No abstract available.

22.

Evaluation of intensified dengue control measures with interrupted time series analysis in the Panadura Medical Officer of Health division in Sri Lanka: a case study and cost-effectiveness analysis.

Liyanage P, Rocklöv J, Tissera H, Palihawadana P, Wilder-Smith A, Tozan Y.

Lancet Planet Health. 2019 May;3(5):e211-e218. doi: 10.1016/S2542-5196(19)30057-9.

23.

Improving clinical management of patients with severe yellow fever.

Wilder-Smith A, Chen LH, Melo A, Visser LG.

Lancet Infect Dis. 2019 Jul;19(7):678-679. doi: 10.1016/S1473-3099(19)30122-7. Epub 2019 May 16. No abstract available.

PMID:
31104910
24.

Application of a targeted-enrichment methodology for full-genome sequencing of Dengue 1-4, Chikungunya and Zika viruses directly from patient samples.

Kamaraj US, Tan JH, Xin Mei O, Pan L, Chawla T, Uehara A, Wang LF, Ooi EE, Gubler DJ, Tissera H, Ng LC, Wilder-Smith A, de Sessions PF, Barkham T, Anderson DE, Sessions OM.

PLoS Negl Trop Dis. 2019 Apr 25;13(4):e0007184. doi: 10.1371/journal.pntd.0007184. eCollection 2019 Apr.

25.

A Prospective Study on the Impact and Out-of-Pocket Costs of Dengue Illness in International Travelers.

Tozan Y, Headley TY, Sewe MO, Schwartz E, Shemesh T, Cramer JP, Eberhardt KA, Ramharter M, Harrison N, Leder K, Angheben A, Hatz C, Neumayr A, Chen LH, De Pijper CA, Grobusch MP, Wilder-Smith A.

Am J Trop Med Hyg. 2019 Jun;100(6):1525-1533. doi: 10.4269/ajtmh.18-0780.

PMID:
30994088
26.

Yellow fever: is Asia prepared for an epidemic?

Wilder-Smith A, Lee V, Gubler DJ.

Lancet Infect Dis. 2019 Mar;19(3):241-242. doi: 10.1016/S1473-3099(19)30050-7. No abstract available.

PMID:
30833057
27.

Dengue.

Wilder-Smith A, Ooi EE, Horstick O, Wills B.

Lancet. 2019 Jan 26;393(10169):350-363. doi: 10.1016/S0140-6736(18)32560-1. Review.

PMID:
30696575
28.

Rapid diagnostic tests for determining dengue serostatus: a systematic review and key informant interviews.

Luo R, Fongwen N, Kelly-Cirino C, Harris E, Wilder-Smith A, Peeling RW.

Clin Microbiol Infect. 2019 Jun;25(6):659-666. doi: 10.1016/j.cmi.2019.01.002. Epub 2019 Jan 18.

29.

Influenza on cruise ships.

Young BE, Wilder-Smith A.

J Travel Med. 2018 Jan 1;25(1). doi: 10.1093/jtm/tay146. No abstract available.

PMID:
30649459
30.

Demonstrating vaccine effectiveness during a waning epidemic: A WHO/NIH meeting report on approaches to development and licensure of Zika vaccine candidates.

Vannice KS, Cassetti MC, Eisinger RW, Hombach J, Knezevic I, Marston HD, Wilder-Smith A, Cavaleri M, Krause PR.

Vaccine. 2019 Feb 4;37(6):863-868. doi: 10.1016/j.vaccine.2018.12.040. Epub 2019 Jan 11.

31.

Can dengue virus be sexually transmitted?

Wilder-Smith A.

J Travel Med. 2019 May 10;26(3). pii: tay157. doi: 10.1093/jtm/tay157. No abstract available.

PMID:
30590715
32.

Novel tools for the surveillance and control of dengue: findings by the DengueTools research consortium.

Wilder-Smith A, Tissera H, AbuBakar S, Kittayapong P, Logan J, Neumayr A, Rocklöv J, Byass P, Louis VR, Tozan Y, Massad E, Preet R.

Glob Health Action. 2018;11(1):1549930. doi: 10.1080/16549716.2018.1549930.

33.

Clinical Pearls in travellers and migrants.

Wilder-Smith A, van Genderen PJ, Barkati S, Coyle C, Staehelin C, Richter J, Bottieau E.

J Travel Med. 2019 Jan 1;26(1). doi: 10.1093/jtm/tay147. No abstract available.

PMID:
30535197
34.

Sentinel Surveillance in Travel Medicine: 20 Years of GeoSentinel Publications (1999-2018).

Wilder-Smith A, Boggild AK.

J Travel Med. 2018 Jan 1;25(1). doi: 10.1093/jtm/tay139. No abstract available.

PMID:
30508133
35.

Risk of severe dengue is higher in patients with sickle cell disease: a scoping review.

Wilder-Smith A, Leong WY.

J Travel Med. 2019 Jan 1;26(1). doi: 10.1093/jtm/tay136. No abstract available.

PMID:
30476342
36.

Development of standard clinical endpoints for use in dengue interventional trials: introduction and methodology.

Jaenisch T, Hendrickx K, Erpicum M, Agulto L, Tomashek KM, Dempsey W, Siqueira JB, Marks MA, Fay MP, Laughlin C, L'Azou M, Leo YS, Narvaez F, Teyssou R, Thomas SJ, Tissera H, Wallace D, Wilder-Smith A, Gubler DJ, Cassetti MC.

BMC Med Res Methodol. 2018 Nov 15;18(1):134. doi: 10.1186/s12874-018-0601-z.

37.

Hell's itch due to sunburn.

Wilder-Smith AJ.

J Travel Med. 2019 Jan 1;26(1). doi: 10.1093/jtm/tay124. No abstract available.

PMID:
30423157
38.

Risk of Dengue in Travelers: Implications for Dengue Vaccination.

Wilder-Smith A.

Curr Infect Dis Rep. 2018 Oct 29;20(12):50. doi: 10.1007/s11908-018-0656-3. Review.

39.

Reply to 'Timing of administration of dengue vaccine in travellers with a recent confirmed dengue infection'.

Wilder-Smith A.

J Travel Med. 2018 Jan 1;25(1). doi: 10.1093/jtm/tay105. No abstract available.

PMID:
30346578
40.

Projecting the end of the Zika virus epidemic in Latin America: a modelling analysis.

O'Reilly KM, Lowe R, Edmunds WJ, Mayaud P, Kucharski A, Eggo RM, Funk S, Bhatia D, Khan K, Kraemer MUG, Wilder-Smith A, Rodrigues LC, Brasil P, Massad E, Jaenisch T, Cauchemez S, Brady OJ, Yakob L.

BMC Med. 2018 Oct 3;16(1):180. doi: 10.1186/s12916-018-1158-8.

41.

Semiannual Versus Annual Influenza Vaccination in Older Adults in the Tropics: An Observer-blind, Active-comparator-controlled, Randomized Superiority Trial.

Young B, Sadarangani S, Haur SY, Yung CF, Barr I, Connolly J, Chen M, Wilder-Smith A.

Clin Infect Dis. 2019 Jun 18;69(1):121-129. doi: 10.1093/cid/ciy836.

PMID:
30277500
42.

Deliberations of the Strategic Advisory Group of Experts on Immunization on the use of CYD-TDV dengue vaccine.

Wilder-Smith A, Hombach J, Ferguson N, Selgelid M, O'Brien K, Vannice K, Barrett A, Ferdinand E, Flasche S, Guzman M, Novaes HM, Ng LC, Smith PG, Tharmaphornpilas P, Yoon IK, Cravioto A, Farrar J, Nolan TM.

Lancet Infect Dis. 2019 Jan;19(1):e31-e38. doi: 10.1016/S1473-3099(18)30494-8. Epub 2018 Sep 5. Review.

PMID:
30195995
43.

Estimating the size of Aedes aegypti populations from dengue incidence data: Implications for the risk of yellow fever outbreaks.

Massad E, Amaku M, Coutinho FAB, Struchiner CJ, Lopez LF, Wilder-Smith A, Burattini MN.

Infect Dis Model. 2017 Dec 8;2(4):441-454. doi: 10.1016/j.idm.2017.12.001. eCollection 2017 Nov.

44.

Zika in travellers 1947-2017: a systematic review.

Wilder-Smith A, Chang CR, Leong WY.

J Travel Med. 2018 Jul 1;25(1). doi: 10.1093/jtm/tay044.

PMID:
30016469
45.

Serostatus-dependent performance of the first licensed dengue vaccine: implications for travellers.

Wilder-Smith A.

J Travel Med. 2018 Aug 1;25(1). doi: 10.1093/jtm/tay057. No abstract available.

46.

Fractional-Dose Yellow Fever Vaccination - Advancing the Evidence Base.

Vannice K, Wilder-Smith A, Hombach J.

N Engl J Med. 2018 Aug 16;379(7):603-605. doi: 10.1056/NEJMp1803433. Epub 2018 Jul 11. No abstract available.

47.

Dengue vaccine: reliably determining previous exposure.

Ariën KK, Wilder-Smith A.

Lancet Glob Health. 2018 Aug;6(8):e830-e831. doi: 10.1016/S2214-109X(18)30295-X. Epub 2018 Jun 22. No abstract available.

48.

Zika vaccines and therapeutics: landscape analysis and challenges ahead.

Wilder-Smith A, Vannice K, Durbin A, Hombach J, Thomas SJ, Thevarjan I, Simmons CP.

BMC Med. 2018 Jun 6;16(1):84. doi: 10.1186/s12916-018-1067-x.

49.

The risk of urban yellow fever resurgence in Aedes-infested American cities.

Massad E, Amaku M, Coutinho FAB, Struchiner CJ, Lopez LF, Coelho G, Wilder-Smith A, Burattini MN.

Epidemiol Infect. 2018 Jul;146(10):1219-1225. doi: 10.1017/S0950268818001334. Epub 2018 May 30.

50.

Leptospirosis among Returned Travelers: A GeoSentinel Site Survey and Multicenter Analysis-1997-2016.

de Vries SG, Visser BJ, Stoney RJ, Wagenaar JFP, Bottieau E, Chen LH, Wilder-Smith A, Wilson M, Rapp C, Leder K, Caumes E, Schwartz E, Hynes NA, Goorhuis A, Esposito DH, Hamer DH, Grobusch MP, For The GeoSentinel Surveillance Network.

Am J Trop Med Hyg. 2018 Jul;99(1):127-135. doi: 10.4269/ajtmh.18-0020. Epub 2018 May 10.

Supplemental Content

Loading ...
Support Center